Michael Collins

Michael has 25 years of reproductive health experience spanning medical affairs, clinical development, drug discovery, scientific communication, regulatory affairs, and managed markets and business development. He has also played an important role in the expansion of the reproductive health business units at both Ferring Pharmaceuticals and Organon Inc.

While at Ferring, Michael held various positions, including Director of Scientific Training, before moving to Director of Strategic Accounts, a role in which he built and led a strategic account team in the successful execution of several high-profile programs and projects.

Michael holds a Master of Science and a Doctor of Philosophy in Reproductive Physiology from Louisiana State University and has published work on many different levels within scientific literature. He is a member of ASRM, The Endocrine Society, and the Society for the Study of Reproduction, where he was appointed to the Annual Meeting Industry Relations Committee in 2013.

At TMRW, Michael spearheads the development, design, and execution of laboratory studies, and then helps to communicate the findings. As a non-clinical scientist, his primary goal is to continue to scientifically define the TMRW platform. He’s passionate about bringing the advancements of cryogenic technology to reproduction.